Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
[ Links ] 100
Experts believe it could be ready in 23 years if studies continue to be successful
The following search algorithm was applied: ((GLP-1 receptor agonist OR glucagon-like peptide-1 receptor agonist OR GIP receptor agonist OR glucose-dependent insulinotropic polypeptide OR liraglutide OR semaglutide OR dulaglutide OR tirzepatide) AND (body composition OR fat mass OR muscle mass OR lean mass OR adiposity OR body fat OR sarcopenia)) AND (clinical trial OR study OR randomized controlled trial OR RCT OR intervention study)
NAK is a volunteer board member of the International Society of Hypertension
The first patch that could effectively deliver these kinds of drugs would open the floodgates to a broader move away from the antiquated needle and syringe, says Michael Schrader, a founder of several startups, including Cambridge-based Vaxess Technologies, which is working on drug-delivery patches
